Unichem Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

279.30 -1.85 ▼-0.7%

16 August 2022, 04:11:10 PM
Volume: 89,882

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.unichemlabs.com
Market Cap 1,966.43 Cr.
Enterprise Value(EV) 2,156.29 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 3.01 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 91.71 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 367.07 Trailing Twelve Months Ending 2022-06
Price to Book Value 0.75 Calculated using Price: 275.90
Dividend Yield 1.45 Period Ending 2022-03
No. of Shares Subscribed 7.04 Cr. 70,405,751 Shares
FaceValue 2
Company Profile
Unichem Laboratories, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.66%
1 Week
-7.90%
1 Month
+2.82%
3 Month
+16.98%
6 Month
+6.48%
1 Year
-1.41%
2 Year
+12.64%
5 Year
+11.61%
10 Year
+62.01%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 16.62 8.95 11.92 10.77 136.04 -0.90 -2.37 1.37 1.32
Return on Capital Employed (%) 21.84 9.29 14.97 13.42 162.77 -1.77 -1.49 2.12 1.04
Return on Assets (%) 11.56 6.55 8.82 7.68 108.06 -0.75 -1.94 1.11 1.06

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 727 817 868 954 1,064 2,680 2,620 2,531 2,557 2,618
Non Curr. Liab. 94 98 74 76 64 46 10 44 49 144
Curr. Liab. 251 230 212 275 393 464 503 567 506 552
Minority Int.
Equity & Liab. 1,073 1,145 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314
Non Curr. Assets 594 564 589 673 772 854 1,094 1,455 1,734 1,666
Curr. Assets 478 581 564 632 748 2,336 2,039 1,686 1,377 1,648
Misc. Exp. not W/O
Total Assets 1,073 1,145 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1,133 1,202 1,333 1,540 1,380 1,188 1,104 1,235 1,270 1,282
Other Income 42 21 19 6 3,278 98 91 50 48 40
Total Income 1,176 1,223 1,352 1,546 4,658 1,287 1,195 1,285 1,317 1,321
Total Expenditure -956 -1,101 -1,169 -1,358 -1,358 -1,269 -1,155 -1,144 -1,197 -1,208
PBIDT 220 122 183 188 3,300 17 40 141 120 113
Interest -3 -3 -3 -3 -8 -8 -8 -5 -6 -8
Depreciation -46 -41 -39 -44 -51 -67 -82 -84 -91 -94
Taxation -43 -2 -29 -33 -696 34 -12 -17 11 11
Exceptional Items -4
PAT 128 75 108 108 2,545 -24 -61 35 34 22
Minority Interest
Share Associate 0 0 0 0 0 1 0 -1 -1
Other Related Items
Consolidated Net Profit 169 75 108 109 2,545 -24 -60 34 33 21
Adjusted EPS 14 8 12 12 362 -3 -9 5 5 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 171 87 78 112 68 -112 -328 20 33 -260
Cash Fr. Inv. -118 36 -52 -85 -128 1,648 -286 -36 -74 100
Cash Fr. Finan. -51 -95 -51 -33 59 -881 -2 -62 -121 191
Net Change 1 28 -25 -7 0 655 -616 -78 -162 32
Cash & Cash Eqvt 25 52 27 20 11 666 197 232 77 109

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93
Public 49.07 49.07 49.07 49.07 49.07 49.07 49.07 49.07 49.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 11 Aug 2022
Annual General Meeting
Unichem Laboratories Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 09-Aug-2022
Thu, 11 Aug 2022
Newspaper Advertisements
Unichem Laboratories Limited has informed the Exchange about Newspaper Advertisements
Wed, 10 Aug 2022
Annual General Meeting
Unichem Laboratories Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 09-Aug-2022

Technical Scans View Details >>

Fri, 12 Aug 2022
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,569.90 +2.0%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Unichem Laboratories Ltd.

Can I Buy Unichem Lab Shares now?
What is the Share Price of Unichem Lab?
What is the Relative Strength Index (RSI) Value of Unichem Lab?
What is the Market Capital (MCAP) of Unichem Lab?
What are the key metrics to analyse Unichem Lab?
What is the Price Performance of Unichem Lab?